(Q41787776)

9 October 2017

Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study (English)

1 reference

9 October 2017

1 reference

1

1 reference

9 October 2017

Gilli M

2

1 reference

9 October 2017

Riccio A

series ordinal

3

1 reference

9 October 2017

Bergamasco B

series ordinal

4

1 reference

9 October 2017

language of work or name

English

0 references

publication date

1 October 1986

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

9 October 2017

1 reference

9 October 2017

49

1 reference

9 October 2017

10

1 reference

9 October 2017

1182-1190

1 reference

Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease

9 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Depression in Parkinson disease: a disabling but neglected factor.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson's disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Altered serotonin metabolism in depressed patients with parkinson's disease.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Is the mesocortical dopaminergic system involved in Parkinson disease?

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Parkinsonism: onset, progression, and mortality

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Depression in rheumatoid disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Patterns of clinical response and plasma dopa levels in Parkinson's disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Cerebral blood flow in dementia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Depression in Patients with Parkinsonism

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

Depression, intellectual impairment, and Parkinson disease.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1029054

The Beck depression inventory with medical inpatients

18 August 2018

1 reference

12 December 2020

1 reference

12 December 2020

Endogenomorphic depression. A conceptual and terminological revision

1 reference

12 December 2020

Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment

1 reference

12 December 2020

Cognitive fluctuations associated with on-off phenomenon in Parkinson disease

1 reference

12 December 2020

1 reference

12 December 2020

Sensory symptoms in parkinsonism related to central dopaminergic function

1 reference

12 December 2020

A method for evaluating disability in patients with Parkinson's disease.

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.49.10.1182

1 reference

9 October 2017

1 reference

9 October 2017

1 reference